Recombinant Human CCL15 Protein，His

CCL15, also known as macrophage inflammatory protein-1 gamma (MIP-1γ), is a chemokine belonging to the CC subfamily that plays a critical role in immune responses and inflammation. It is primarily produced by various immune cells, including monocytes, and is involved in the recruitment of leukocytes to sites of injury or infection. Research has indicated that CCL15 may have implications in several pathological conditions, particularly in cancer, where it can influence tumor microenvironments and contribute to tumor progression and metastasis. Furthermore, studies have suggested that CCL15 could serve as a potential biomarker for certain diseases and a therapeutic target in immunological therapies. The recombinant production of CCL15 protein has become pivotal in these investigations, allowing for the detailed study of its biological functions and mechanisms. Scientists utilize recombinant CCL15 in various experimental setups, including cell signaling assays, migration assays, and in vivo models to explore its effects on immune cell behavior and interactions. Understanding the functions and mechanisms of CCL15 can provide insights into its roles in health and disease, paving the way for novel therapeutic strategies that harness its properties to modulate immune responses in various clinical settings. Thus, the study of recombinant CCL15 protein not only enhances our understanding of chemokine biology but also contributes to the development of innovative approaches for managing inflammatory diseases and cancer.